A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin.
The interaction of L-tryptophan and four benzodiazepine derivatives with tyrosine-modified human serum albumin was investigated by equilibrium dialysis and circular dichroism measurements. Out of the 18 tyrosine residues of the human serum albumin molecule, only 9 could be modified with tetranitromethane. At least up to a degree of modification of 5, the conformation of human serum albumin was not changed and no crosslinking and fractionation has been found, as revealed from circular dichroism measurements in the far ultraviolet range and from SDS polyacrylamide electrophoresis. The modification of only 2 out of the 9 accessible tyrosine residues of human serum albumin strongly affects the binding of L-tryptophan and diazepam to their common, stereospecific bindining site. This was evidently shown by a reduction of the association constants by more than 90% and by a large reduction of the extrinsic Cotton effects of four benzodiazepines bound to human serum albumin. The numbers of binding sites remained unchanged. Strong evidence was presented that only one tyrosine residue, which reacts faster with tetranitromethane than all others, is mainly involved in the specific indole and benzodiazepine binding site of human serum albumin. The location of this highly reactive tyrosine residue and that of the specific indole and benzodiazepine binding site within the human serum albumin primary structure is discussed.
D001569:Benzodiazepines / Q000097:blood*; D001665:Binding Sites; D006801:Humans; D007211:Indoles / Q000097:blood*; D011485:Protein Binding; D011487:Protein Conformation; D012709:Serum Albumin / Q000378:metabolism*; D013434:Sulfenic Acids; D013774:Tetranitromethane; D014364:Tryptophan / Q000097:blood; D014443:Tyrosine / Q000097:blood*
D007211:Indoles; D012709:Serum Albumin; D013434:Sulfenic Acids; D001569:Benzodiazepines; D014443:Tyrosine; D014364:Tryptophan; D013774:Tetranitromethane